Recent Event Highlights: Former Solvay Pharmaceuticals, Inc. Chief Takes Lead Role at Startup Selecta Biosciences, Inc., Deal Economy 2010: Abbott's Murphy on healthcare M&A, Dishman set to benefit from Abbott-Solvay deal, Abbott Buys Solvay's Drugs Unit for 4.5B Euros, Abbott To Acquire Solvay Pharmaceuticals Business, Solvay Pharmaceuticals/The Right Formula, and 9 more...
Created by dipity on Sep 28, 2009
Last updated: 10/23/10 at 02:04 AM
Solvay Pharmaceuticals has no followers yet. Be the first one to follow.
Excerpt
Former Solvay Pharmaceuticals, Inc. Chief Werner Cautreels, Ph.D. Takes Lead Role at Startup Selecta Biosciences, Inc.
8/16/2010
WATERTOWN, Mass.--(BUSINESS WIRE)--Selecta Biosciences, Inc., a biopharmaceutical company
Source Info
Biospace
Related Topics
http://www.biospace.com/news_story.aspx?StoryID=191066&full=1
Abbott Laboratories (NYSE:ABT) for the second straight year took home the Most Admired Corporate Dealmaker award in the pharma-biotech category. The pharmaceutical firm has executed $30 billion in transactions in the past decade, $10 billion of that coming since January, including the $6.6 billion cash acquisition of Solvay Pharmaceuticals SA in September. Sean Murphy, vice president for new business development, says Abbott will remain active in 2010, but he expects overall deal active in the industry to slow. - Suzanne Stevens
美國能放幾個胚胎？ Fertility Guidelines Updated on Number of Embryos to Be Transferred During In Vitro Fertilization Fran Lowry Authors and Disclosures Physician Rating: ( 3 Votes ) Rate This Article: Print This Email this INFORMATION FROM INDUSTRY Advances in understanding osteoclast-induced bone loss The RANK-Ligand Pathway appears to be an essential mediator of osteoclast-induced bone loss in postmenopausal osteoporosis. Read more October 20, 2009 — The American Society for Reproductive Medicine (ASRM) and the Society for Assisted Reproductive Technology (SART) have released new guidelines for the number of embryos to be transferred in in vitro fertilization cycles in an effort to reduce high-risk multiple pregnancies. The guidelines, based on ASRM and SART data from 2007, were published online October 19 in Fertility and Sterility. "High-order multiple pregnancy (three or more implanted embryos) is an undesirable consequence (outcome) of assisted reproductive technologies (ART)," the guidelines state. "Multiple gestations lead to an increased risk of complications in both the fetuses and the mothers." The guidelines are meant to assist ART programs and patients to determine the appropriate number of cleavage-stage (usually 2 or 3 days after fertilization) embryos or blastocysts (usually 5 or 6 days after fertilization) to transfer, and they can be modified according to the patient's age, embryo quality, and the opportunity for cryopreservation. They may also be ...
Excerpt
...The contractual obligations of the Solvay Pharma entities after the acquisition by Abbott remain unchanged,” Mr Roland Kaut, Solvay Pharmaceuticals GmbH, told Business Line. Dishman has a 10-year deal till 2013 with Solvay, said Dishman Pharmaceuticals’ Managing...
Source Info
Hindu Business Line
http://www.thehindubusinessline.com/2009/09/30/stories/2009093051650200.htm
Excerpt
...branding. Solvay has also come under investigation by U.S. authorities for allegedly paying generic drug makers Watson Pharmaceuticals and Par Pharmaceutical Companies to delay generic competition. Shares in Solvay initially opened higher, but later reversed...
Source Info
FOX Business
http://feeds.foxbusiness.com/~r/foxbusiness/industrials/~3/Sdc_Qv53Ss4/
Excerpt
...and long-term pharmaceutical growth. Miles White, chairman and chief executive officer of Abbott, said: "The acquisition of Solvay Pharmaceuticals further diversifies our pharmaceutical portfolio, expands our presence in key high-growth emerging markets, enhances...
Source Info
Pharmaceutical Business Review
http://www.pharmaceutical-business-review.com/news/abbott_to_acquire_solvay_pharmaceuticals_business_090928/
Production sponsored by Solvay Pharmaceuticals. Written and directed by me. DP the great Ulf Aneer. Awesome Motion Graphics by Peter Bäckgren. Producer was Karin Carriage. Produced in 2007.
PyongSu Pharma is the first western and North Korean joint venture (JV) company in the medical field. In 2008 it was recognized by the government as one of North Korea's very best JV out of approx. 200 JVs. It was then also regarded as the so-called Model Company for the North Korean pharmaceutical industry and it shared its know-how with pharmaceutical factories to help raise their quality and safety standards and thereby save additional lives. This video was PyongSu's introduction to donor organisations and individuals that had been purchasing pharmaceuticals abroad and shipped to North Korea instead of sourcing them domestically as they did not trust the quality and safety of drugs made by the local pharmaceutical industry. PyongSu's promotional presentation explained to them why they can and should place their orders with PyongSu rather than with pharmaceutical companies abroad. As PyongSu had no budget to mandate a professional advertising company with the task its managing director Felix Abt made the concept, the script and produced it in-house towards the end of 2005, with the help of volunteering North Korean IT and designing students and their Canadian trainer Ian Lee as well as teacher Michael P. Spavor, then giving language courses in Pyongyang, who was the "voice" in this clip. Thus, this unique commercial was made in its entirety in Pyongyang (and by people who are not advertising professionals). Check it out and add your comment! (And, yes, hitherto highly ...
Solvay Pharmaceuticals, Inc., virtualizes its data center with the Intel® Xeon® processor 5300 series.
Video: Patrick Balster
Stephen Hill, President and CEO of Solvay Pharmaceuticals; Ken Stewart, Commissioner for the State of Georgia Department of Economic Development; Clifton Baile, CEO of InsectiGen, Inc.; Phillip Street, attorney with Kilpatrick Stockton and co-chair of their Health and Life Sciences; Ed Schutter, President and COO of Sciele Pharma; all speak on the importance of attending the 2009 Bio International Convention. convention.bio.org
Stephen Hill, President and CEO of Solvay Pharmaceuticals; Ken Stewart, Commissioner for the State of Georgia Department of Economic Development; Clifton Baile, CEO of InsectiGen, Inc.; Phillip Street, attorney with Kilpatrick Stockton and co-chair of their Health and Life Sciences; Ed Schutter, President and COO of Sciele Pharma; all speak on the value of networking at the 2009 Bio International Convention. convention.bio.org
Stephen Hill, President and CEO of Solvay Pharmaceuticals, speaks on the importance of attending the 2009 Bio International Convention. convention.bio.org
Zie ook: www.neuropathie.nu Vitamine, het woord komt van het Latijn: vita = leven; en van aminen (bepaalde chemische verbindingen). Vitaminen zijn naast de essentiële aminozuren en vetzuren noodzakelijke bestanddelen van ons voedsel. Vitaminen zijn organische verbindingen die als katalysatoren bij stofwisselingsreacties of als redoxactieve membraanbestanddelen in de cel gebruikt worden. Omdat ze in het organisme niet of in onvoldoende mate gesynthetiseerd kunnen worden, moeten ze via het voedsel worden opgenomen. Vandaar dat ze essentieel zijn. Enkele vitamines worden gwel emaakt in het lichaam, zoals vitamine K door darmbacteriën, vitamine D in de huid onder invloed van zonlicht. De naamgeving vitamine stamt af van de ontdekking dat de ziekte beri-beri veroorzaakt werd door een gebrek aan thiamine (vitamine B1) in het voedsel. Dit amine bleek dus essentieel voor de gezondheid. Sindsdien worden alle organische spoorverbindingen in de voeding vitaminen genoemd. Het eerste boek over deze materie was van de hand van de Duitser Casimir Funk, die dit boek schreef in 1914! De geschiedenis van de vitamines begon in het begin van de 19 de eeuw en is nauw verwant met de inzet van een aantal Nederlandse artsen en bacteriologen. Een paar mijlpalen: 1747: De Schotse marine chirurg James Lindin ontdekte dat de stof die later bekend werd als vitamine C het dodelijke scheurbuik kon voorkomen. 1906: De Engelse biochemist Sir Frederick Gowland Hopkins ontdekte dat bepaalde voedingsstoffen ...
Excerpt
Solvay Pharmaceuticals Inc. has scrapped plans to build a $300 million flu drug plant which Birmingham Mayor Larry Langford said was destined for the city.
Solvay, in a Tuesday news release, said it will not submit a proposal to seek additional funding
Source Info
Birmingham Business Journal
http://feeds.bizjournals.com/~r/bizj_birmingham/~3/407574305/daily20.html
brandalarm bij Solvay Pharmaceuticals betrof loos alarm
Bruce McMillan of Solvay Pharmaceuticals talks about the benefits of virtualization using VMware Infrastructure 3, including savings of more than $1.5 million which won them the Pioneer IT Award for their virtualization project. Solvay also has some virtual machines that have uptimes of better than 600 days.
Ixis Capital, now Natixis, talks about the hardware and operational expense reductions, manageability enhancements, and business continuity benefits of running a virtual infrastructure with VMware Infrsatructure 3. Learn more: www.vmware.com
Excerpt
MUMBAI:
Dishman Pharmaceuticals & Chemicals Ltd will acquire the fine chemicals,
vitamin D and vitamin D analogues business of Solvay Pharmaceuticals for an
undisclosed amount.
As part of
this deal, all facilities, people and activities at Solvay's
Source Info
Economic Times
http://economictimes.indiatimes.com/Dishman_acquires_Solvays_fine_chemicals/rssarticleshow/2187687.cms
Excerpt
...reduced food intake," Solvay said in a statement. The $25 million will be booked into the fourth quarter 2006 figures but Solvay Pharmaceuticals is increasing its R&D and marketing spending by a similar amount. "Consequently, the guidance given to the markets...
Source Info
Reuters
http://feeds.feedburner.com/~r/reuters/healthNews/~3/58544372/newsarticle.aspx
Excerpt
...attn. Ms. F.M. Jeuken PO Box 900 1380 DA Weesp The Netherlands E-mail: No recruitment agency applications please. P.O. Box 900, 1380 DA Weesp Tel. +31 (0)294 477 000 www.solvaypharmaceuticals.nl www.beterleven.nl ...
Source Info
Nature.com
http://naturejobs.nature.com/texis/jobsearch/details.html?id=44a036b74a01b0&lookid=nature
Update Sources